P. Ledwon

692 total citations
11 papers, 100 citations indexed

About

P. Ledwon is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, P. Ledwon has authored 11 papers receiving a total of 100 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Reproductive Medicine, 4 papers in Obstetrics and Gynecology and 3 papers in Surgery. Recurrent topics in P. Ledwon's work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Intraperitoneal and Appendiceal Malignancies (2 papers). P. Ledwon is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Intraperitoneal and Appendiceal Malignancies (2 papers). P. Ledwon collaborates with scholars based in Germany, Australia and United States. P. Ledwon's co-authors include Jalid Sehouli, W. Lichtenegger, Oumar Camara, Dirk Stengel, Peter Klare, Dirk Elling, Jens‐Uwe Blohmer, G. Heinrich, Alexander Mustea and Marek Zygmunt and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

P. Ledwon

10 papers receiving 98 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Ledwon Germany 6 67 47 43 35 17 11 100
Giuseppe Cucinella Italy 7 62 0.9× 33 0.7× 92 2.1× 24 0.7× 17 1.0× 38 141
Ioannis Kotsopoulos United Kingdom 6 25 0.4× 22 0.5× 30 0.7× 34 1.0× 13 0.8× 17 91
Dirk Brinkmann United Kingdom 5 35 0.5× 23 0.5× 43 1.0× 16 0.5× 8 0.5× 11 84
Jaime Siegrist Spain 6 36 0.5× 29 0.6× 42 1.0× 12 0.3× 7 0.4× 16 74
Stephanie Kuku United Kingdom 3 24 0.4× 23 0.5× 39 0.9× 17 0.5× 15 0.9× 4 87
Carlos Eduardo Mattos da Cunha Andrade Brazil 7 74 1.1× 82 1.7× 53 1.2× 22 0.6× 13 0.8× 18 139
Reena Merard United Kingdom 6 38 0.6× 35 0.7× 21 0.5× 17 0.5× 13 0.8× 7 80
G Balagué France 7 35 0.5× 78 1.7× 37 0.9× 63 1.8× 21 1.2× 7 127
Ann Whitehouse Australia 3 41 0.6× 17 0.4× 49 1.1× 27 0.8× 42 2.5× 3 156
Coriolan Lebreton France 5 47 0.7× 11 0.2× 16 0.4× 44 1.3× 12 0.7× 28 76

Countries citing papers authored by P. Ledwon

Since Specialization
Citations

This map shows the geographic impact of P. Ledwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Ledwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Ledwon more than expected).

Fields of papers citing papers by P. Ledwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Ledwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Ledwon. The network helps show where P. Ledwon may publish in the future.

Co-authorship network of co-authors of P. Ledwon

This figure shows the co-authorship network connecting the top 25 collaborators of P. Ledwon. A scholar is included among the top collaborators of P. Ledwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Ledwon. P. Ledwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Armbrust, Robert, P. Ledwon, Anne von Rüsten, Constanze Schneider, & Jalid Sehouli. (2022). Primary Treatment Results in Patients with Ovarian, Fallopian or Peritoneal Cancer—Results of a Clinical Cancer Registry Database Analysis in Germany. Cancers. 14(19). 4638–4638. 5 indexed citations
2.
Zack, Fred, Matthias W. Beckmann, Sibylle Banaschak, et al.. (2018). Venöse Luftembolie bei vaginalen Verletzungen durch Geschlechtsverkehr. Rechtsmedizin. 29(1). 21–29. 5 indexed citations
3.
Koensgen, Dominique, Jalid Sehouli, Antje Belau, et al.. (2017). Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer. International Journal of Gynecological Cancer. 27(3). 500–506. 11 indexed citations
4.
Mustea, Alexander, Dominique Koensgen, Antje Belau, et al.. (2013). Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology). Cancer Chemotherapy and Pharmacology. 72(5). 975–983. 13 indexed citations
6.
Koensgen, Dominique, Antje Belau, Jalid Sehouli, et al.. (2011). Adjuvant sequential chemo-radiation therapy in high-risk endometrial cancer: Results of a prospective, multicenter phase II study of the NOGGO.. Journal of Clinical Oncology. 29(15_suppl). 5109–5109. 1 indexed citations
7.
Döcke, F, et al.. (2009). Oestrogen Priming for the Positive Oestrogen Feedback: Site of Action*). Experimental and Clinical Endocrinology & Diabetes. 94(04/05). 55–60.
8.
Sehouli, Jalid, Dirk Stengel, Alexander Mustea, et al.. (2007). Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO. Cancer Chemotherapy and Pharmacology. 61(2). 243–250. 27 indexed citations
9.
Sehouli, Jalid, Dirk Stengel, Oumar Camara, et al.. (2002). A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy. Annals of Oncology. 13(11). 1749–1755. 29 indexed citations
10.
Sehouli, Jalid, W. Lichtenegger, Dominique Koensgen, et al.. (2001). Relapsed ovarian cancer after failure of first-line chemotherapy with platin and paclitaxel — a phase II study. European Journal of Cancer. 37. S323–S324. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026